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Dimension reduction and clustering
Summarizing the data
• Dimension reduction: find some principal components
explaining the major variability in the data
• Clustering: find some clusters explaining the major
heterogeneity of the data
Link between dimension reduction and clustering
Often when visualizing the data one is interested in visualizing
clusters on the visualization space.
In practice
Dimension reduction and clustering are performed separately
or sequentially but rarely simultaneously.
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Combining dimension reduction and clustering
through probabilistic models
Generative models allow to combine visualization and
clustering
• Tibshirani & Hastie (1996): Reduced rank discriminant
analysis
• Kumar & Andreou (1998): Heteroscedastic discriminant
analysis
• Bouveyron & Brunet (2012): Model-based clustering and
visualization in the Fisher discriminative subspace
In a rigorous probabilistic way
• A unique homogeneous criterion to optimize: the likelihood
• Simultaneous selection of the number clusters and of the
number of components: BIC
• Missing data naturally taken into account: EM algorithm
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Multi-objective clustering
Motivation: clustering part
• Usually clustering summarizes the data information by only
one latent variable, the clustering variable.
• But we would like to allow for several views of the data
with potentially more than one clustering variable.
• Often performances of clustering methods measured
based on classification of reference, but many possible
references in many settings (sex, species, status, ...).
Motivation: visualisation part
• View each clustering variable on a clustering component
• Heterogeneity-based visualisation rather than
inertia-based visualisation
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Illustration (1/2)
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Illustration (2/2)
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Outline
1. Probabilistic interpretation of the factorial discriminant
analysis
2. Multi-objective mixture model
3. Estimation of the parameters and model choice
4. Experiments on simulated and real datasets
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Linear discriminant analysis (LDA)
Data
• x ∈ Rd : the observed continuous variables
• z ∈ {1, . . . ,K} : the cluster (latter considered as unknown)
Assumptions
n independent replicates of (x , z)
• z ∼ Mult(π1, . . . , πK ) with πk = p(zk = 1)
• ∀k ∈ {1, . . . ,K}, x |zk = 1 ∼ Nd (µk ,Σ)
Parameters estimation
π̂k =
nk
n , µ̂k = x̄k and Σ̂ = W (empirical within-class covariance matrix)
Classification
p(zk = 1|x , θ̂) =
π̂kφd (x ; µ̂k , Σ̂)∑K
k ′=1 π̂k ′φd (x ; µ̂k ′ , Σ̂)
⇒ ẑ = argmax
k∈{1,...,K}
µ̂TkΣ̂
−1x−1
2
µTkΣ̂
−1µk−log(π̂k )
⇒ linear classification boundary.
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Factorial discriminant analysis (FDA)
FDA principle
• The first component of FDA finds v1 ∈ Rdmaximizing the variance
explained by the cluster:
v1 = arg max
v∈Rd
v TBv
v T(W + B)v
= arg max
v∈Rd
v TBv
v TWv
with B the empirical between class covariance matrix.
• v1 is given by the eigen vector associated with the highest eigen value
of W−1B
• The remaining discriminant components are obtained through the
remaining eigen vectors of W−1B
Remark: The number of non null eigen-values of W−1B is at most
min(d ,K − 1).
Classification rule
If components within class variance is scaled to one, classification can be
performed by nearest class center with the Euclidean distance on the
projected data.
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Illustration of FDA
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Equivalence between LDA and FDA
Campbell (1984)
FDA⇔ LDA s.c. rank({µ1, . . . ,µK}) = p, where p ≤ K − 1.
Reparametrization of LDA under constrains
x |zk = 1 ∼ Nd
(
A
(
νk
γ
)
,AAT
)
where νk ∈ Rp, γ ∈ Rd−p and A ∈Md ,d (R).
Generative interpretation
Let y ∈ Rp and u ∈ Rd−p. The generative model is:
• Draw z : z ∼ Mult(1;π1, . . . , πK )
• Draw y |z : y |zk = 1 ∼ Np(νk , Ip)
• Draw u : u ∼ Nd−p(γ, Id−p)
• Compute x based on y and u :
x = A
(
y
u
)
z y
u
x
n
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Posterior class membership probabilities
Posterior probabilities
Let V ∈Mp,d (R) and R ∈Md−p,d (R) the matrices such that
y = Vx , u = Rx . Obviously
(
V
R
)
= A−1.
p(zk = 1|x) = p(zk = 1|y ,u) = p(zk = 1|y) = p(zk = 1|Vx).
Vx conveys all the clustering information.
p(zk = 1|x) =
πkφp(Vx ;νk , Ip)∑K
k ′=1 πk ′φp(Vx ;νk ′ , Ip)
.
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Parameters estimation
`(θ; x, z) = n log
∣∣∣∣det(VR
)∣∣∣∣− 12
classifiying︷ ︸︸ ︷
n∑
i=1
K∑
k=1
zik‖Vx i − νk‖2
−1
2
n∑
i=1
‖Rx i − γ‖2︸ ︷︷ ︸
not classifying
−n
2
log(2π) +
n∑
i=1
K∑
k=1
zik log(πk ).
Maximum likelihood estimation
• V̂ and R̂ are obtained through eigen value decomposition
of W−1B.
• ν̂1, . . . , ν̂K and γ̂ explicit given V̂ and R̂.
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Application in the clustering setting (z unknown)
EM algorithm
Until convergence iterate the following steps:
• E step: Compute t(r+1)ik = p(z i |x i ;θ
(r))
• M step:
• Compute t (r+1)ik -weighted versions of W , B and x̄k
• Deduce V (r+1) and R(r+1), ν(r+1)1 , . . . , ν
(r+1)
K and γ
(r+1)
Remark
When p < min(K − 1,d), not equivalent to perform a standard
EM algorithm and then perform FDA at the end of the EM
algorithm.
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Presentation of the model (supervised setting)
Model description
• H independent class variables
• z1, . . . , zH with K1, . . . ,KH
modalities
• p(zhk = 1) = π
h
k
• H classifying latent variables
• yh ∈ Rph with ph ≤ Kh − 1
• yh|zhk = 1 ∼ Nph (νhk , Iph )
• Not classifying latent variables
• u ∈ Rd−p• with p• =
∑H
h=1 ph
• u ∼ Nd−p•(γ, Id−p•)
• x defined by x =

V 1
...
V H
R

−1 
y1
...
yH
u
 .
z2 y2
z1 y1
u
x
n
Figure: Illustration for
H = 2
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Possible models and number of parameters
Remarks
• Need to choose H, K1, . . . , KH and p1, . . . , pH : possible
selection by model choice.
• V 1, . . . , V H and R estimated up to isometric
transformations.
Number of parameters
dim(Θ) =
H∑
h=1
(Kh−1)+
H∑
h=1
ph(2Kh + 2d − ph + 1)
2
+
(d − p•)(d + p• + 3)
2
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Estimation in the supervised setting
• The likelihood cannot be maximized directly⇒ alternate
optimisation.
• Constrain V (r+1)h and R
(r+1) to be linear combinations of
V (r)h and R
(r), the parameters of other clustering dimension
being fixed:(
V (r+1)h
R(r+1)
)
= M
(
V (r)h
R(r)
)
=
(
M1
M2
)(
V (r)h
R(r)
)
,
• by denoting yh(r) = V (r)h x and u
(r) = R(r)x ,
• finding M and other parameters is equivalent to perform
probabilistic FDA on the data
(
yh(r)
u(r)
)
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Estimation in the unsupervised setting
Similar to the supervised setting except that the data at each
iteration are now weighted by thik
(r+1) instead of zhik
EM algorithm
Until convergence, for h ∈ {1, . . . ,H} iterate the following steps:
• E step: compute
thik
(r+1)
= p(zhi |x i ;θ(r)) =
πkφph (y
h
i
(r)
;νhk
(r)
, Iph )∑K
k ′=1 πk ′φph (y
h
i
(r)
;νhk ′
(r)
, Iph )
• M step: update V h, R, νh1 , . . . , ν
h
Kh
, πh1 , . . . , π
h
Kh
and γ
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Simulated data set: illustration
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Simulated data: model choice
• Performed using the BIC criterion
BIC = `(x ; θ̂)− dim(Θ)
2
log n
• Model collection: H = 2, K1 ∈ {1, . . . ,5}, K2 ∈ {1, . . . ,5},
p1 = p2 = 1
K1 \ K2 1 2 3 4 5
1 -1414.69 -1395.53 -1397.55 -1395.65 -1396.88
2 -1383.76 -1384.64 -1397.17 -1393.86
3 -1384.05 -1396.36 -1395.36
4 -1392.30 -1394.01
5 -1389.14
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Crabs data set
200 crabs morphological data, 5 morphological variables, 50
males orange, 50 males blue, 50 females orange, 50 females
blue.
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PCA on the crab data set
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−0.5 0.0 0.5
●
●●●
● ●● ●● ●●
● ●●
●●
●● ●●●
●
●● ●
● ●
●● ●
●
●
● ● ●●
● ●●
●
●●
●
●●
●
●●
●
●●
●●
● ● ●●●
●●
●
●●
●
●
●●●●
●
● ●●●
●
●
● ●
●
●●
●
●
●●
●
●
●
● ●●●
●● ●● ●● ●
● ● ●
● ●
● ●●●● ●●
●
● ●●
●●
●●●
●●
●
●●● ●
●● ●
●
●●
●
● ●
●
●●
●
● ●
●● ●
●● ●●●
●
● ●
●●
●
●
●● ●● ●●
●
●
● ●
●
●●
●
● ●●●
●
−0.2 0.0 0.2 0.4
●
●● ●
● ●● ●● ●●
●● ●●
●
●
●● ●● ● ●●●
●
● ● ●
●●
●● ●
● ●
●
● ●● ●
● ●●
●
●●
●
● ●
●
●●
●
● ●
●●●
● ●● ● ●● ●
● ●
●●
●●
●
● ●●●
●
● ●●●
● ●
●
●●
●
●●
●
●
●● ● ●
●
−
4
0
2
4
●
● ●●●
●●●● ●● ●
●● ●●
●
●●
●●●● ● ●● ●
●
●● ●
●●
● ●●
● ●●
●
●●
●● ●
●
● ●
●
●
●
●
●
● ●
●● ●
●●● ● ●●
●●
●●
● ●
●
●● ● ●
●
●●●
● ●
●
● ●
●
●●
●
●
● ●● ●
●
−
0.
5
0.
5
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●●
●
●●
●
●●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●●
●●
●
●
●
●
● ●●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
Comp.2
●
●
●●
●
●
● ●
●
●
●
● ●
●
●
●
●
●
●●
●
●●
●
●
●●
●
● ●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●●
●
●●
●
●
●
●●
●
●●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
● ● ●●
●
●
●● ●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●●
●
●
●●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
● ●
●
●
●●
●
● ●
●
● ●
● ●
●●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
● ●
●
●●
●
●
● ●● ●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●●
●
●●
●
●
●
●
●
●
●●
●●
●
●
●
●●●
●
●
●
●
●
●
●
●
●●
●●
●
●●●●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●●
● ●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●●
●
●
●
●●●
●
●
●
●
●
●
●
●●
● ●
●●
●
●● ●
●●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●●
●
Comp.3
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●●
●
●
●
●
●●
● ●
●
●
●
●● ●
●
●
●
●
●
●
●
●
●● ●
● ●
●
●●●
●
● ●
●●
●
●
●
●●
● ●
●
●
●
●
●
●
●
●
●
● ●
●
−
0.
6
−
0.
2
0.
2
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
● ●
● ●
●
●
●
● ●
●
●
●
●
●
●
●
● ●
● ●●
●●
●
●● ●● ●●
● ●
●
●
●
●
● ●
●
● ●
●
●
●
●
● ●
●
−
0.
2
0.
0
0.
2
0.
4
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
Comp.4
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
−4 0 2 4
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
−0.6 −0.2 0.2
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
● ●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
−0.10 0.00 0.10
−
0.
10
0.
00
0.
10
Comp.5
Data after PCA
22/28
Introduction Probabilistic interpretation of FDA Multi-objective mixture model Estimation of the parameters Experiments
FDA on the crab data set: supervised setting
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Introduction Probabilistic interpretation of FDA Multi-objective mixture model Estimation of the parameters Experiments
FDA on the crab data set: unsupervised setting
var 1
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Introduction Probabilistic interpretation of FDA Multi-objective mixture model Estimation of the parameters Experiments
Principal clustering components: H = 2, K1 = K2 = 2,
p1 = p2 = 1
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Introduction Probabilistic interpretation of FDA Multi-objective mixture model Estimation of the parameters Experiments
Principal clustering components: model choice
• Performed using the BIC criterion
• Model collection: H = 2, K1 ∈ {1, . . . ,5}, K2 ∈ {1, . . . ,5},
p1 = p2 = 1
K1 \ K2 1 2 3 4 5
1 -313.02 -252.35 -244.20 -250.60 -249.40
2 -229.73 -254.76 -254.82 -233.91
3 -248.82 -255.49 -233.17
4 -238.88 -231.19
5 -269.75
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Introduction Probabilistic interpretation of FDA Multi-objective mixture model Estimation of the parameters Experiments
Principal clustering components: H = 2, K1 = 4,
K2 = 5, p1 = p2 = 1
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Introduction Probabilistic interpretation of FDA Multi-objective mixture model Estimation of the parameters Experiments
Conclusion and perspectives
Conclusion
• model combining visualization and clustering with many
clustering view points
• possibility to perform model choice
Perspectives
• consider sparse estimates of the R matrix for the high
dimensional setting
• extension to the heteroscedastic setting
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